Peritoneal macrophages are impaired in cathelicidin-deficient mice systemically challenged with Escherichia coli
- PMID: 33496883
- DOI: 10.1007/s00441-020-03362-y
Peritoneal macrophages are impaired in cathelicidin-deficient mice systemically challenged with Escherichia coli
Abstract
Cathelicidins are small, cationic peptides produced by macrophages with protective effects against infection although their involvement in phagocytosis is not fully understood. This study demonstrates that fewer macrophages were recruited in mice genetically deficient in cathelicidin (Camp-/-) during acute Escherichia coli-induced peritonitis and those macrophages had impaired phagocytosis. These defects seem due to endogenous functions of murine cathelicidin (CRAMP) as phagocytosis was not improved by synthetic human cathelicidin (LL-37) in a murine phagocytic cell line. This knowledge contributes to understanding the function of cathelicidins in the recruitment and function of phagocytic cells and differential roles between endogenous and exogenous cathelicidins.
Keywords: Cathelicidin; Escherichia coli; Macrophage; Phagocytosis.
Similar articles
-
The antimicrobial peptide cathelicidin protects mice from Escherichia coli O157:H7-mediated disease.PLoS One. 2012;7(10):e46476. doi: 10.1371/journal.pone.0046476. Epub 2012 Oct 15. PLoS One. 2012. PMID: 23077510 Free PMC article.
-
Bacterial subversion of cAMP signalling inhibits cathelicidin expression, which is required for innate resistance to Mycobacterium tuberculosis.J Pathol. 2017 May;242(1):52-61. doi: 10.1002/path.4878. Epub 2017 Mar 15. J Pathol. 2017. PMID: 28097645 Free PMC article.
-
A role for connexin43 in macrophage phagocytosis and host survival after bacterial peritoneal infection.J Immunol. 2008 Dec 15;181(12):8534-8543. doi: 10.4049/jimmunol.181.12.8534. J Immunol. 2008. PMID: 19050272 Free PMC article.
-
Therapeutic Potential of Cathelicidin Peptide LL-37, an Antimicrobial Agent, in a Murine Sepsis Model.Int J Mol Sci. 2020 Aug 19;21(17):5973. doi: 10.3390/ijms21175973. Int J Mol Sci. 2020. PMID: 32825174 Free PMC article. Review.
-
Roles and Mechanisms of Human Cathelicidin LL-37 in Cancer.Cell Physiol Biochem. 2018;47(3):1060-1073. doi: 10.1159/000490183. Epub 2018 May 25. Cell Physiol Biochem. 2018. PMID: 29843147 Review.
References
-
- Barlow PG, Li Y, Wilkinson TS, Bowdish DM, Lau YE, Cosseau C, Haslett C, Simpson AJ, Hancock RE, Davidson DJ (2006) The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system. J Leukoc Biol 80:509–520 - DOI
-
- Blyth GAD, Connors L, Fodor C, Cobo ER (2020) The network of colonic host defense peptides as an innate immune defense against enteropathogenic bacteria. Front Immunol 11:965 - DOI
-
- Bowdish DM, Davidson DJ, Lau YE, Lee K, Scott MG, Hancock RE (2005) Impact of LL-37 on anti-infective immunity. J Leukoc Biol 77:451–459 - DOI
-
- Chromek M, Arvidsson I, Karpman D (2012) The antimicrobial peptide cathelicidin protects mice from Escherichia coli O157:H7-mediated disease. PLoS One, vol 7
-
- Chromek M, Slamová Z, Bergman P, Kovács L, Podracká L, Ehrén I, Hökfelt T, Gudmundsson GH, Gallo RL, Agerberth B, Brauner A (2006) The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med 12:636–641 - DOI
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical